Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations - Report - MDSpire

Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations

  • By

  • Camille M. Moore

  • Shu-Yi Liao

  • Cheyret Wood

  • Arunangshu Sarkar

  • Jonathan H. Cardwell

  • Kristyn MacPhail

  • Margaret M. Mroz

  • Christina Riley

  • Kara Mould

  • Clara I. Restrepo

  • Li Li

  • Lisa A. Maier

  • Ivana V. Yang

  • May 26, 2026

  • 0 min

Share

Clinical Report: Transcriptomic Profiles and Intercellular Interactions in Lung Immune Cells Related to Sarcoidosis

Overview

This study characterizes the transcriptomic profiles and intercellular interactions of lung immune cells in patients with pulmonary sarcoidosis. Significant differences in gene expression and cell interactions were identified between sarcoidosis patients and healthy controls, highlighting potential targets for further research.

Background

Sarcoidosis is a granulomatous disease primarily affecting the lungs, characterized by immune dysregulation and chronic inflammation. Understanding the cellular and molecular mechanisms involved in sarcoidosis is crucial for developing better diagnostic and therapeutic strategies. Recent advances in single-cell RNA sequencing provide insights into the immune landscape of this complex disease.

Data Highlights

Cell TypeGene Expression Changes
Resident MacrophagesUpregulation of IL1R1, PSTPIP2, TAPBP
Recruited MacrophagesDownregulation of AKT1, ACKR3, AZU1
Proliferating MacrophagesUpregulation of CCL4
B CellsSignificant reduction in number
CD4+ T CellsActivation of TNF, IFNG, IL1B

Key Findings

  • Significant differential expression of genes associated with sarcoidosis in various macrophage populations.
  • Reduction in B cell numbers in sarcoidosis patients compared to controls.
  • Distinct transcriptional alterations in CD4+ T cells, indicating immune dysregulation.
  • Overall reduction in cell interactions, with a relative increase in CD4+ T cell interactions in sarcoidosis.
  • Downregulation of LGALS9-CD45 signaling observed in sarcoidosis patients.

Clinical Implications

The findings suggest that specific immune cell populations, particularly macrophages and T cells, play a critical role in the pathogenesis of pulmonary sarcoidosis. Understanding these cellular interactions may aid in the development of targeted therapies and improve diagnostic accuracy.

Conclusion

This study enhances our understanding of the immune landscape in pulmonary sarcoidosis and identifies potential molecular targets for future research. Further investigation is warranted to explore the clinical implications of these findings.

Related Resources & Content

  1. Clinical Research in Cardiology, 2026 -- The inflammatory fingerprint reveals immune cell populations associated with disease activity in cardiac sarcoidosis
  2. conexiant -- Airway Resistome Higher In Chronic Lung Disease
  3. Frontiers in Immunology -- Transcriptomic analysis reveals immune dysregulation and identifies key genes in ICU patients with severe ARDS
  4. Clinical Rheumatology (Springer) -- Identification of Th17-associated genes PGAP1 and TMBIM1 as promising biomarkers for diagnosis and prognosis in systemic sclerosis: Insights from bioinformatics and murine studies
  5. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine
  6. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate | New England Journal of Medicine
  7. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine
  8. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate | New England Journal of Medicine

Original Source(s)

Related Content